Literature DB >> 4962464

A controlled study of haloperidol in chronic schizophrenia.

G M Simpson, J W Angus, J G Edwards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4962464

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  4 in total

1.  Placebo response in antipsychotic clinical trials: a meta-analysis.

Authors:  Bret R Rutherford; Emily Pott; Jane M Tandler; Melanie M Wall; Steven P Roose; Jeffrey A Lieberman
Journal:  JAMA Psychiatry       Date:  2014-12-01       Impact factor: 21.596

Review 2.  Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis.

Authors:  R Beresford; A Ward
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

3.  Dose equivalents for second-generation antipsychotics: the minimum effective dose method.

Authors:  Stefan Leucht; Myrto Samara; Stephan Heres; Maxine X Patel; Scott W Woods; John M Davis
Journal:  Schizophr Bull       Date:  2014-02-03       Impact factor: 9.306

4.  Imputation methods for missing outcome data in meta-analysis of clinical trials.

Authors:  Julian P T Higgins; Ian R White; Angela M Wood
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.